نتائج البحث - Megan I. Samuelson

  • يعرض 1 - 4 نتائج من 4
تنقيح النتائج
  1. 1
    Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

    Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing حسب Jianling Bi, A.M. Newtson, Yuping Zhang, Eric J. Devor, Megan I. Samuelson, Kristina W. Thiel, Kimberly K. Leslie

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Preferential recognition of a microbial metabolite by human V 2V 2 T cells

    Preferential recognition of a microbial metabolite by human V 2V 2 T cells حسب Kia Joo Puan, Jin Chen, H. Wang, Ghanashyam Sarikonda, Amy M. Raker, H. K. Lee, Megan I. Samuelson, E. Märker‐Hermann, Ljiljana Paša‐Tolić, E. Nieves, José‐Luis Giner, Tomohisa Kuzuyama, Craig T. Morita

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study

    A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study حسب David Bender, Michael W. Sill, Heather A. Lankes, Henry Reyes Pineda, Christopher J. Darus, James E. Delmore, Jacob Rotmensch, Heidi J. Gray, Robert S. Mannel, Jeanne M. Schilder, Mark Hunter, Carolyn K. McCourt, Megan I. Samuelson, Kimberly K. Leslie

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    <i>TP53</i> Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

    <i>TP53</i> Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology... حسب Kristina W. Thiel, Eric J. Devor, Virginia L. Filiaci, David G. Mutch, Katherine Moxley, Angeles Alvarez Secord, Krishnansu S. Tewari, Megan McDonald, Cara Mathews, Casey Cosgrove, Summer Dewdney, Carol Aghajanian, Megan I. Samuelson, Heather A. Lankes, Robert A. Soslow, Kimberly K. Leslie

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: